What is Inlyta (Axitinib)
Inlyta is a targeted therapy and is a receptor protein-kinase inhibitor. Axitinib is the generic name.
Drug Manufacturer / Marketeer :
M/s Pfizer Inc.
1MG & 5MG TABLETS.
Inlyta® is indicated for treatment of advanced renal cell carcinoma after failure of 1 prior systemic therapy.
For treatment related information, please consult your treating Physician.
- Inlyta 1 mg tablets are red film coated, oval tablets, available in
bottles of 180
- Inlyta 5 mg tablets are red film coated, triangular tablets available in bottles of 60
Storage and handling:
Store at 20° to 25° C, excursions permitted to 15° to 30° C
How do we source the Drug?
SMIQ Pharma will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is also essential.
Company that Manufactures/ Markets:
M/s Pfizer Inc
Assistance Cell in India:
For ONCOLOGY DRUG: INLYTA (Axitinib) Tablets 1MG & 5MG price.
Contact us @ +91 7678048225 or by email firstname.lastname@example.org.